Proton-dependent multidrug efflux systems

1.0kCitations
Citations of this article
271Readers
Mendeley users who have this article in their library.

Abstract

Multidrug efflux systems display the ability to transport a variety of structurally unrelated drugs from a cell and consequently are capable of conferring resistance to a diverse range of chemotherapeutic agents. This review examines multidrug efflux systems which use the proton motive force to drive drug transport. These proteins are likely to operate as multidrug/proton antiporters and have been identified in both prokaryotes and eukaryotes. Such proton-dependent multidrug efflux proteins belong to three distinct families or superfamilies of transport proteins: the major facilitator superfamily (MFS), the small multidrug resistance (SMR) family, and the resistance nodulation/cell division (RND) family. The MFS consists of symporters, antiporters, and uniporters with either 12 or 14 transmembrane- spanning segments (TMS), and we show that within the MFS, three separate families include various multidrug/proton antiport proteins. The SMR family consists of proteins with four TMS, and the multidrug efflux proteins within this family are the smallest known secondary transporters. The RND family consists of 12-TMS transport proteins and includes a number of multidrug efflux proteins with particularly broad substrate specificity. In gram- negative bacteria, some multidrug efflux systems require two auxiliary constituents, which might enable drug transport to occur across both membranes of the cell envelope. These auxiliary constituents belong to the membrane fusion protein and the outer membrane factor families, respectively. This review examines in detail each of the characterized proton-linked multidrug efflux systems. The molecular basis of the broad substrate specificity of these transporters is discussed. The surprisingly wide distribution of multidrug efflux systems and their multiplicity in single organisms, with Escherichia coli, for instance, possessing at least nine proton-dependent multidrug efflux systems with overlapping specificities, is examined. We also discuss whether the normal physiological role of the multidrug efflux systems is to protect the cell from toxic compounds or whether they fulfil primary functions unrelated to drug resistance and only efflux multiple drugs fortuitously or opportunistically.

References Powered by Scopus

A comprehensive set of sequence analysis programs for the VAX

12900Citations
N/AReaders
Get full text

Whole-genome random sequencing and assembly of Haemophilus influenzae Rd

4853Citations
N/AReaders
Get full text

Biochemistry of multidrug resistance mediated by the multidrug transporter

3667Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance

3385Citations
N/AReaders
Get full text

Microbial heavy-metal resistance

1968Citations
N/AReaders
Get full text

Major facilitator superfamily

1656Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Paulsen, I. T., Brown, M. H., & Skurray, R. A. (1996). Proton-dependent multidrug efflux systems. Microbiological Reviews. American Society for Microbiology. https://doi.org/10.1128/mmbr.60.4.575-608.1996

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 110

65%

Researcher 33

20%

Professor / Associate Prof. 23

14%

Lecturer / Post doc 3

2%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 79

47%

Biochemistry, Genetics and Molecular Bi... 50

30%

Immunology and Microbiology 25

15%

Chemistry 15

9%

Save time finding and organizing research with Mendeley

Sign up for free